O-仲丁基羟胺盐酸盐 | 6084-59-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: O-仲丁基羟胺盐酸盐
• 英文名称: O-sec-butylhydroxylamine hydrochloride
• 英文别名: O-2-butylhydroxylamine hydrochloride；sec-butyloxyamine hydrochloride；sec-butyloxyamine hydrochloride salt；O-(butan-2-yl)hydroxylamine hydrochloride；O-butan-2-ylhydroxylamine;hydrochloride
• CAS: 6084-59-9
• 化学式: C₄H₁₁NO*ClH
• mdl: MFCD16877208
• 分子量: 125.598
• InChiKey: TXSFSGZYQWSOEX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.93
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  35.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  O-仲丁基羟胺盐酸盐 、 4-[(5R,10S,13R,14S,17R)-14-羟基-10,13-二甲基-3-氧代-2,4,5,6,7,8,9,11,12,15,16,17-十二氢-1H-环戊并[a]菲-17-基]-5H-呋喃-2-酮 在 吡啶 作用下， 以 甲醇 为溶剂， 反应 2.5h， 生成
  参考文献：
  名称：

  Synthesis and biological evaluation of RON-neoglycosides as tumor cytotoxins

  摘要：

  Cardenolides such as digitoxin have been shown to inhibit cancer cell growth, to reduce cancer metastasis, and to induce apoptosis in tumor cells. Among the most potent digitoxin-based cytotoxins identified to date are MeON-neoglycosides generated via oxyamine neoglycosylation. Here, we report our studies of oxyamine neoglycosylation aimed at facilitating the elucidation of linkage-diversified digitoxin neoglycoside structure-activity relationships. We identified conditions suitable for the convenient synthesis of digitoxin neoglycosides and found that sugar structure, rather than RON-glycosidic linkage, exerts the strongest influence on neoglycoside yield and stereochemistry. We synthesized a library of digitoxin neoglycosides and assessed their cytotoxicity against eight human cancer cell lines. Consistent with previous findings, our data show that the structure of RON-neoglycosidic linkages influences both the potency and selectivity of digitoxin neoglycosides. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.carres.2011.09.019
• 作为产物：
  描述：

  O-(2-butyl)-N-hydroxyphthalimide 在 肼 作用下， 以 乙醇 、 水 为溶剂， 反应 2.0h， 以20.9%的产率得到O-仲丁基羟胺盐酸盐
  参考文献：
  名称：

  High; Prior; Bell, Journal of Pharmacology and Experimental Therapeutics, 1999, vol. 288, # 2, p. 490 - 501

  摘要：

  DOI：

文献信息

• Design, synthesis and evaluation of wound healing activity for β-sitosterols derivatives as potent Na+/K+-ATPase inhibitors
  作者：Shaoyu Cui、Hongli Jiang、Lei Chen、Jian Xu、Wenzhuo Sun、Haopeng Sun、Zijian Xie、Yunhui Xu、Fubai Yang、Wenyuan Liu、Feng Feng、Wei Qu

  DOI：10.1016/j.bioorg.2019.103150

  日期：2020.5

  demonstrated. Na+/K+-ATPase, more than a pump, its signal transduction function for involvement in cell growth regulation attracts widespread concern. The Na+/K+-ATPase/Src receptor complex can serve as a receptor involved in multiple signaling pathways including promoting wound healing pathways. To finding potent accelerating wound healing small molecular, we choose the high inhibitory activity of Na+/K+-ATPase

  β-谷甾醇是一种常见的类固醇，可以在多种植物中鉴定出来，并且已证明它们在促进伤口愈合方面具有功效。Na + / K + -ATPase不仅仅是一种泵，其参与细胞生长调节的信号转导功能引起了广泛关注。Na + / K + -ATPase / Src受体复合物可作为参与多种信号途径（包括促进伤口愈合途径）的受体。为了找到有效的加速伤口愈合的小分子，我们选择了具有高抑制活性的Na + / K + -ATPase和无心脏毒性的天然化合物β-谷甾醇作为底物。设计，合成和评估了一系列β-谷甾醇衍生物，作为潜在的Na + / K + -ATPase抑制剂。其中，化合物31、47、49对Na + / K + -ATPase的抑制活性增强，IC50值分别为3.0μM，3.4μM，2.2μM，比β-谷甾醇的IC50 7.6μM更有效。特别地，化合物49可以诱导L929成纤维细胞中的细胞增殖，迁移和可溶性胶原蛋
• 甾醇类衍生物及其制备方法和应用
  申请人：中国药科大学

  公开号：CN106800580B

  公开（公告）日：2019-05-10

  本发明公开了β‑谷甾醇、β‑豆甾醇以及胆固醇的甾醇类衍生物，如式VI表示。本发明还公开了该甾醇类衍生物的制备方法。本发明还公开了该甾醇类衍生物在制备促伤口愈合药物方面的应用。本发明从易得的天然产物出发，分别以β‑谷甾醇、β‑豆甾醇以及胆固醇为起始原料，合成方法简单，具有较好的可操作性和反应收率。制得的甾醇类衍生物具有明显的促伤口愈合活性，对L929成纤维细胞的增殖、迁移及胶原合成能力均明显高于原料和阳性对照药重组人碱性成纤维细胞生长因子(bFGF)。本发明制得的甾醇类衍生物相比蛋白类药物(如bFGF)，其剂型和用药方式也更加多样化，为其在促伤口愈合领域中的应用提供参考。
• Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates
  作者：Elisa Nuti、Elisabetta Orlandini、Susanna Nencetti、Armando Rossello、Alessio Innocenti、Andrea Scozzafava、Claudiu T. Supuran

  DOI：10.1016/j.bmc.2007.01.023

  日期：2007.3

  A series of sulfonylated hydroxamates were synthesized and evaluated as dual inhibitors of both human carbonic anhydrases (hCAs) and matrix metalloproteinases (MMPs), two metalloenzyme families involved in carcinogenesis and tumor invasion processes. The new derivatives were tested on three CA isozymes, the cytosolic isozymes I and II, and the transmembrane, tumor-associated isozyme IX, and also on

  合成了一系列磺酰化的异羟肟酸酯，并将其评估为人类碳酸酐酶（hCAs）和基质金属蛋白酶（MMPs）的双重抑制剂，这两种金属酶家族参与致癌和肿瘤侵袭过程。在三种CA同工酶（胞质同工酶I和II，以及跨膜，与肿瘤相关的同工酶IX）以及人明胶酶（MMP-2和MMP-9）上测试了新衍生物。一些新的衍生物被证明是CA II的有效抑制剂和选择性抑制剂，但是只有化合物3b和6b（没有芳基磺酰基部分）对hCA IX的抑制活性比对hCA I和II的抑制作用要好，在微摩尔范围内。
• S_NAr or Sulfonylation? Chemoselective Amination of Halo(het)arene Sulfonyl Halides for Synthetic Applications and Ultralarge Compound Library Design
  作者：Vasyl Naumchyk、Vladyslav A. Andriashvili、Dmytro S. Radchenko、Dmytro Dudenko、Yurii S. Moroz、Andrey A. Tolmachev、Serhii Zhersh、Oleksandr O. Grygorenko

  DOI：10.1021/acs.joc.3c02636

  日期：2024.3.1

  The chemoselectivity of halo(het)arene sulfonyl halide aminations is studied thoroughly under parallel synthesis conditions, and the scope and limitations of the method are established. It is shown that SNAr-reactive sulfonyl halides typically undergo sulfonamide synthesis during the first step; the second amination is also possible provided that the SNAr-active center is sufficiently reactive. On

  在平行合成条件下深入研究了卤代（杂）芳烃磺酰卤胺化物的化学选择性，并确定了该方法的范围和局限性。结果表明， SN Ar反应性磺酰卤通常在第一步中进行磺酰胺合成；如果SN Ar活性中心具有足够的反应性，则第二次胺化也是可能的。相反，带有芳基化部分的磺酰氟在适当的控制下在后一个反应中心发生选择性转化。进一步的硫-氟化物交换（SuFEx）也是可能的，这对于某些磺酰卤类特别有价值。开发的两步并行双胺化方案提供了对 66.7 亿个化合物的合成可处理 REAL 型化学空间的访问（预期合成成功率 76%）。
• Synthesis, and In vitro and In vivo muscarinic pharmacological properties of a series of 1,6-Dihydro-5-(4 H )-pyrimidinone oximes
  作者：Ralf Plate、Marc J.M. Plaum、Peter Pintar、Christan G. Jans、Thijs de Boer、Fred A. Dijcks、Ge Ruigt、John S. Andrews

  DOI：10.1016/s0968-0896(98)00074-1

  日期：1998.9

  A series of 1,6-dihydro-5-(4H)-pyrimidinone oxime derivatives I was synthesized (Scheme 1, Tables 1 and 2) and tested for muscarinic activity (Table 3) in receptor binding assays using [H-3]-oxotremorine-M (Oxo-M) and [H-3]-pirenzepine pirenzepine (Pz) as ligands. Potential muscarinic agonistic or antagonistic properties of the compounds were determined using binding studies that measured their potencies to inhibit the binding of Oxo-M and Pz. Preferential inhibition of Oxo-M binding was used as an indicator for potential muscarinic agonistic properties; this potential was confirmed in functional studies on isolated organs. The series produced a wide range of active compounds with differing degrees of selectivity in M-1, M-2, and M-3 functional models. Several compounds that have mixed agonist/antagonist profiles were able to reduce cholinergic-related cognitive impairments in models of mnemonic function. Substitutions (I, e.g. R-2 or R-3 = Me) at the 1,6-dihydro-5-(4H)pyrimidine ring disrupted binding and efficacy, whereas systematic variation of the oximes substituent R1 resulted in various degrees of potency and selectivity dependent on the nature of the substitution. (C) 1998 Elsevier Science Ltd. All rights reserved.